Cargando…

Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluation

OBJECTIVES: The increasing incidence of chronic liver disease (CLD) in the UK may be attributed to a rise in preventable risk factors, including hazardous alcohol use and type 2 diabetes. Transient elastography (TE) can rapidly stratify risk of CLD in primary care populations and provide an opportun...

Descripción completa

Detalles Bibliográficos
Autores principales: Knight, Holly, Harman, David, Morling, Joanne R, Aithal, Guruprasad, Card, Timothy, Guha, Indra Neil, Bains, Manpreet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677335/
https://www.ncbi.nlm.nih.gov/pubmed/33208336
http://dx.doi.org/10.1136/bmjopen-2020-041574
_version_ 1783611949727088640
author Knight, Holly
Harman, David
Morling, Joanne R
Aithal, Guruprasad
Card, Timothy
Guha, Indra Neil
Bains, Manpreet
author_facet Knight, Holly
Harman, David
Morling, Joanne R
Aithal, Guruprasad
Card, Timothy
Guha, Indra Neil
Bains, Manpreet
author_sort Knight, Holly
collection PubMed
description OBJECTIVES: The increasing incidence of chronic liver disease (CLD) in the UK may be attributed to a rise in preventable risk factors, including hazardous alcohol use and type 2 diabetes. Transient elastography (TE) can rapidly stratify risk of CLD in primary care populations and provide an opportunity to raise patient awareness of risk factors. This study explores patients’ experiences of TE screening in a primary care setting. In addition, patient awareness of CLD risk is explored. STUDY DESIGN AND SETTING: This study used a qualitative process evaluation of a community screening pathway for CLD (Nottingham, UK). Participants completed semistructured interviews, which were audio-recorded, transcribed verbatim and analysed thematically. PARTICIPANTS: Twenty adults were purposively recruited 6 months to 2 years after TE screening. Inclusion criteria included (1) hazardous alcohol use, (2) type 2 diabetes and/or (3) persistently elevated liver enzymes without known cause. RESULTS: Undergoing TE in primary care was seen as acceptable to most participants. Hazardous alcohol use was identified as the primary cause of CLD; no participants were aware of metabolic risk factors. TE improved understanding of personal risk factors and prompted contemplation of lifestyle changes across all TE stratifications. However, participants’ perceptions of risk were altered by the healthcare providers’ communication of TE scores. CONCLUSIONS: High acceptability of TE, regardless of the risk factor, provides strong support for inclusion of TE stratification in primary care. Findings highlight the positive impact of receiving TE on risk awareness. Future clinical iterations should improve the structure and communication of TE results to patients.
format Online
Article
Text
id pubmed-7677335
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-76773352020-11-30 Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluation Knight, Holly Harman, David Morling, Joanne R Aithal, Guruprasad Card, Timothy Guha, Indra Neil Bains, Manpreet BMJ Open Public Health OBJECTIVES: The increasing incidence of chronic liver disease (CLD) in the UK may be attributed to a rise in preventable risk factors, including hazardous alcohol use and type 2 diabetes. Transient elastography (TE) can rapidly stratify risk of CLD in primary care populations and provide an opportunity to raise patient awareness of risk factors. This study explores patients’ experiences of TE screening in a primary care setting. In addition, patient awareness of CLD risk is explored. STUDY DESIGN AND SETTING: This study used a qualitative process evaluation of a community screening pathway for CLD (Nottingham, UK). Participants completed semistructured interviews, which were audio-recorded, transcribed verbatim and analysed thematically. PARTICIPANTS: Twenty adults were purposively recruited 6 months to 2 years after TE screening. Inclusion criteria included (1) hazardous alcohol use, (2) type 2 diabetes and/or (3) persistently elevated liver enzymes without known cause. RESULTS: Undergoing TE in primary care was seen as acceptable to most participants. Hazardous alcohol use was identified as the primary cause of CLD; no participants were aware of metabolic risk factors. TE improved understanding of personal risk factors and prompted contemplation of lifestyle changes across all TE stratifications. However, participants’ perceptions of risk were altered by the healthcare providers’ communication of TE scores. CONCLUSIONS: High acceptability of TE, regardless of the risk factor, provides strong support for inclusion of TE stratification in primary care. Findings highlight the positive impact of receiving TE on risk awareness. Future clinical iterations should improve the structure and communication of TE results to patients. BMJ Publishing Group 2020-11-18 /pmc/articles/PMC7677335/ /pubmed/33208336 http://dx.doi.org/10.1136/bmjopen-2020-041574 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Public Health
Knight, Holly
Harman, David
Morling, Joanne R
Aithal, Guruprasad
Card, Timothy
Guha, Indra Neil
Bains, Manpreet
Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluation
title Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluation
title_full Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluation
title_fullStr Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluation
title_full_unstemmed Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluation
title_short Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluation
title_sort acceptability of chronic liver disease screening in a uk primary care setting: a qualitative evaluation
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677335/
https://www.ncbi.nlm.nih.gov/pubmed/33208336
http://dx.doi.org/10.1136/bmjopen-2020-041574
work_keys_str_mv AT knightholly acceptabilityofchronicliverdiseasescreeninginaukprimarycaresettingaqualitativeevaluation
AT harmandavid acceptabilityofchronicliverdiseasescreeninginaukprimarycaresettingaqualitativeevaluation
AT morlingjoanner acceptabilityofchronicliverdiseasescreeninginaukprimarycaresettingaqualitativeevaluation
AT aithalguruprasad acceptabilityofchronicliverdiseasescreeninginaukprimarycaresettingaqualitativeevaluation
AT cardtimothy acceptabilityofchronicliverdiseasescreeninginaukprimarycaresettingaqualitativeevaluation
AT guhaindraneil acceptabilityofchronicliverdiseasescreeninginaukprimarycaresettingaqualitativeevaluation
AT bainsmanpreet acceptabilityofchronicliverdiseasescreeninginaukprimarycaresettingaqualitativeevaluation